These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7745966)

  • 1. Characterization of an oxidation-resistant tumor cell line and its sensitivity to immune response and chemotherapy.
    Sauri H; Kim AT; Shau H
    J Surg Res; 1995 May; 58(5):526-35. PubMed ID: 7745966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of lymphokine-activated killer- and natural killer-mediated cytotoxicities by neutrophils.
    Shau HY; Golub SH
    J Immunol; 1989 Aug; 143(3):1066-72. PubMed ID: 2787346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human tumor cell line resistance to chemotherapeutic agents does not predict resistance to natural killer or lymphokine-activated killer cell-mediated cytolysis.
    Harker WG; Tom C; McGregor JR; Slade L; Samlowski WE
    Cancer Res; 1990 Sep; 50(18):5931-6. PubMed ID: 1975512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compared mechanisms of tumor cytolysis by human natural killer cells and activated polymorphonuclear leukocytes.
    Abrams SI; Brahmi Z
    J Immunol; 1984 Jun; 132(6):3192-6. PubMed ID: 6327820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics and mechanism of neutrophil-mediated cytostasis induced by tumor necrosis factor.
    Shau H
    J Immunol; 1988 Jul; 141(1):234-40. PubMed ID: 3379304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to natural killer cell-mediated cytolysis by a pleiotropic drug-resistant human erythroleukemia (K562-R) cell line.
    Yanovich S; Hall RE; Weinert C
    Cancer Res; 1986 Sep; 46(9):4511-5. PubMed ID: 2425955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Red cell regulation of tumor necrosis factor-induced human neutrophil cytostatic activity.
    Shau HY
    Cancer Commun; 1991 Sep; 3(9):283-6. PubMed ID: 1911044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia and resistance to hydrogen peroxide confer resistance to tumor necrosis factor in murine L929 cells.
    Park YM; Anderson RL; Spitz DR; Hahn GM
    Radiat Res; 1992 Aug; 131(2):162-8. PubMed ID: 1641471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
    Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
    Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of natural killer cell line NK-92-mediated cytolysis (NK-92-lysis) with the surface markers of major histocompatibility complex class I antigens, adhesion molecules, and Fas of target cells.
    Komatsu F; Kajiwara M
    Oncol Res; 1998; 10(10):483-9. PubMed ID: 10338151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The over-expression of P-glycoprotein in K-562 and DAUDI cells, is associated with a high susceptibility to NK and LAK cells.
    Dupuis ML; Ramoni C; Yassen A; Samoggia P; Tombesi M; Caserta M; Cianfriglia M
    J Biol Regul Homeost Agents; 1991; 5(4):137-41. PubMed ID: 1687102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential oxygen radical susceptibility of adriamycin-sensitive and -resistant MCF-7 human breast tumor cells.
    Mimnaugh EG; Dusre L; Atwell J; Myers CE
    Cancer Res; 1989 Jan; 49(1):8-15. PubMed ID: 2535695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-4 inhibits IL-2 induction of LAK cytotoxicity in lymphocytes from a variety of lymphoid tissues.
    Colquhoun SD; Economou JS; Shau H; Golub SH
    J Surg Res; 1993 Nov; 55(5):486-92. PubMed ID: 8231167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced susceptibility of cis-diamminedichloroplatinum-treated K562 cells to lysis by peripheral blood lymphocytes and lymphokine activated killer cells.
    Mizutani Y; Bonavida B; Nio Y; Yoshida O
    Cancer; 1993 Feb; 71(4):1313-21. PubMed ID: 7679609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of lymphokine-activated killer induction by neutrophils.
    Shau HY; Kim A
    J Immunol; 1988 Dec; 141(12):4395-402. PubMed ID: 3264311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of susceptibility to NK lysis in cisplatin-resistant K562 cell lines.
    Dedoussis G; Menounos P; Papadopoulos N; Gounaris A; Karameris A
    Anticancer Res; 1998; 18(4C):3081-5. PubMed ID: 9713514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deposition of reactive oxygen metabolites onto and within living tumor cells during neutrophil-mediated antibody-dependent cellular cytotoxicity.
    Cao D; Boxer LA; Petty HR
    J Cell Physiol; 1993 Aug; 156(2):428-36. PubMed ID: 8344997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphokine-activated killer cell susceptibility and multidrug resistance in small cell lung carcinoma.
    Savas B; Kerr PE; Ustun H; Cole SP; Pross HF
    Anticancer Res; 1998; 18(6A):4355-61. PubMed ID: 9891492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of PKC and ROS in the cytotoxic mechanism of anti-leukemic decursin and its derivatives and their structure-activity relationship in human K562 erythroleukemia and U937 myeloleukemia cells.
    Kim HH; Sik Bang S; Seok Choi J; Han H; Kim IH
    Cancer Lett; 2005 Jun; 223(2):191-201. PubMed ID: 15896453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Target cell membrane modification and susceptibility to lymphokine-activated killer cell-mediated lysis. II. Sodium periodate has a differential effect on the lysis of human and murine tumor cells.
    Midis GP; Gupta VK; Fabian DF; Lefor AT
    J Surg Res; 1994 Feb; 56(2):146-54. PubMed ID: 8121171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.